MUDr. Anna Panovská, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 2215, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 112
2011
-
Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.
Year: 2011, type: Conference abstract
-
The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients
Year: 2011, type: Conference abstract
-
Vlasatobuněčná leukémie
Postgraduální medicína, year: 2011, volume: 13, edition: 3
-
Výsledky recentních velkých randomizovaných studií léčby CLL.
Year: 2011, type: Requested lectures
2010
-
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.
Annals of Oncology, year: 2010, volume: 21, edition: 12, DOI
-
Co víme o incidenci chronické lymfocytární leukemie (CLL), a kde a jak jsou nemocní s CLL léčeni?
Transfuze a Hematologie dnes, year: 2010, volume: 16, edition: 1
-
Epidemiologie chronické lymfocytární leukemie (CLL), aneb kde končí monoklonální B lymfocytóza a začíná CLL.
Year: 2010, type: Conference abstract
-
Chronic Lymphocytic Leukemia and Focusing on Epidemiology and Management in Everyday Hematologic Practice: Recent Data From the Czech Leukemia Study Group for Life (CELL)
Clinical Lymphoma, Myeloma & Leukemia, year: 2010, volume: 10, edition: 4
-
Rituximab in combination with high-dose dexamethasone: an effective treatment option for patients with relapsed/refractory chronic lymphocytic leukemia
Year: 2010, type: Conference abstract
-
Rituximab v kombinaci s vysokodávkovaným Dexamethasonem: efektivní léčebná modalita u pacientů s relabující/refrakterní chronickou lymfocytární leukemií.
Year: 2010, type: Conference abstract